This Promising GLP-1 Drug Could Renew Novo Nordisk Hope
Novo Nordisk has faced headwinds, but a new GLP-1 drug could change the game. This article breaks down what investors...
Some tax planning strategies can significantly reduce your tax bill. Learn about key techniques to improve your financial strategy.
23,434 articlesNovo Nordisk has faced headwinds, but a new GLP-1 drug could change the game. This article breaks down what investors...
A fresh cash bid for Two Harbors Investment Corp. sparks a renewed bidding war, putting pressure on UWM to top terms ...
A Seattle federal judge denied Northwest MLS's bid to dismiss Compass’s antitrust lawsuit, keeping the Compass case o...
When markets pull back, investors ask a simple but serious question: should you buy the Invesco QQQ ETF during stock ...
Tech weakness pressured theStreet today, dragging the broader market even as select companies posted government contr...
Pfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
Investors are seeing a mining stock flying this week, led by SSR Mining. This piece breaks down the catalysts beyond ...
Investors are buzzing about Oklo as the Aurora Powerhouse regulatory path becomes clearer. This piece breaks down wha...
McDonald’s posted better-than-expected first-quarter sales, yet higher gas prices and consumer anxiety threaten momen...
Wedbush raises Apple’s price target to $400, arguing a coming AI shift could position Apple as the main AI distributi...
Bitcoin holds near a critical level as CME's volatility futures near launch, stoking bets on a push toward the mid-80...
A senior policy voice close to U.S. foreign affairs says Washington may have a strategic setback in Iran, signaling t...